Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets.
about
Poly-L-Lysine induces fibrosis on alginate microcapsules via the induction of cytokines.Novel experimental strategies to prevent the development of type 1 diabetes mellitus.Reversal of beta-cell suppression in vitro in pancreatic islets isolated from nonobese diabetic mice during the phase preceding insulin-dependent diabetes mellitusInterleukin 1 inhibits insulin secretion from isolated rat pancreatic islets by a process that requires gene transcription and mRNA translation.Antidiabetic effects of interleukin 1.The effect of capsule composition on the biocompatibility of alginate-poly-l-lysine capsules.In intact islets interstitial GABA activates GABA(A) receptors that generate tonic currents in α-cells.Altered expression of somatostatin receptors in pancreatic islets from NOD mice cultured at different glucose concentrations in vitro and in islets transplanted to diabetic NOD mice in vivo.Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxideHyperglycemia-induced B cell toxicity. The fate of pancreatic islets transplanted into diabetic mice is dependent on their genetic background.Modification of adverse inflammation is required to cure new-onset type 1 diabetic hostsDistinct differences in the responses of the human pancreatic β-cell line EndoC-βH1 and human islets to proinflammatory cytokines.IL-1β reciprocally regulates chemokine and insulin secretion in pancreatic β-cells via NF-κB.Innate inflammation in type 1 diabetesDifferential roles of Mac-1+ cells, and CD4+ and CD8+ T lymphocytes in primary nonfunction and classic rejection of islet allograftsInterleukin-1 antagonism moderates the inflammatory state associated with Type 1 diabetes during clinical trials conducted at disease onset.Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice.Biochemical and molecular actions of interleukin-1 on pancreatic beta-cells.Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trialsNew perspectives on the structure and function of the normal and diabetic beta-cell.Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis.Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus.Cytokines as immune effector molecules in autoimmune endocrine diseases with special reference to insulin-dependent diabetes mellitus.Gevokizumab in type 1 diabetes mellitus: extreme remedies for extreme diseases?Immunotherapies currently in development for the treatment of type 1 diabetes.Short-term glucosamine infusion increases islet blood flow in anesthetized rats.Expression of an insulin/interleukin-1 receptor antagonist hybrid gene in insulin-producing cell lines (HIT-T15 and NIT-1) confers resistance against interleukin-1-induced nitric oxide production.Involvement of the proteasome in IL-1beta induced suppression of islets of Langerhans in the rat.Interleukin-1 beta (IL-1) does not reduce the diabetes incidence in diabetes-prone BB rats.The effect of interleukin-1 on the thyroid gland.Islet amyloid deposits preferentially in the highly functional and most blood-perfused islets.Increased glucose oxidation and contents of insulin and ATP in polyamine-depleted rat insulinoma cells (RINm5F).The dynamic plasticity of insulin production in β-cells.Insulin-secreting beta-cells possess specific receptors for interleukin-1 beta.T-cell-directed treatment strategies for Type 1 diabetes and the confounding role of inflammation.Inhibition of insulin secretion from rat islets of Langerhans by interleukin-6. An effect distinct from that of interleukin-1.Signal transduction of stress via ceramide.Interleukin 1 is a potent stimulator of islet insulin secretion and phosphoinositide hydrolysis.Targeting Innate Immunity for Type 1 Diabetes Prevention.Differential effects of cytokines on long-term mitogenic and secretory responses of fetal rat pancreatic beta-cells.
P2860
Q34082895-C3D17D4D-59F5-460B-B366-40AD2F436652Q34091863-A3F9179F-ABBC-4BCB-AA0F-AF84FE105B97Q34253666-9471E6E7-F519-4E5E-BDEC-738B7F101D90Q34260486-6AF1A148-5B21-4015-8B27-BBD604BF51BDQ34294763-D32ACC9A-E51F-4917-ACF8-08EDE160E958Q34656792-30E7ABDA-252F-4777-99B6-FAAD08312B8AQ34796718-12C58EEA-2EDB-41FB-8BD0-7C347036B025Q35196943-8D4B5B7C-5BA7-4B78-832B-35C71BE3D2FAQ35613483-B3C7D58B-1F24-4E12-B87E-539B2325ACFCQ35818698-D371301E-F001-49BD-A5E4-896AD47ADEB3Q35928910-B3D90350-38AF-494E-AF19-6A7BAFA21236Q36114154-BA6D57A7-6525-4DED-B2A3-32F17D9F8923Q36174390-0D55AB65-E23C-4393-AB70-E1FA67255119Q36225939-DCF80A1A-AFD1-417E-8A5A-8B26DCE02C9BQ36351978-7180F9C5-278B-4EE7-B5BA-28A1A33A09EEQ36788764-B934237B-1F1B-42BD-943F-3F7AFB3BF7E4Q36945031-DBC7D032-CE38-48A0-B229-79984F75897AQ37119520-9A707512-4FD4-4CE1-BBEE-F3115A952977Q37307777-518AA3EA-EF97-4ABF-9F9B-72DD5B208B4AQ37312606-3710DFB9-8244-4D7D-92E8-148AE7DD17D4Q37618805-DD9CC374-C9A3-4678-B8D5-8FBE8EAD1921Q37832964-E899534B-A6D6-412F-9126-B0D5CDCFD4BDQ38219284-13BFEF2F-C88B-43BB-8BF1-244ECC7FBC00Q38235580-508B3BB3-0110-4C6C-A8DE-95472ED394FDQ38585822-4502C48A-27B6-4439-AF98-2C7FF3BCF533Q39246006-43DB5E47-487E-4FA6-8B6B-9277A9F6FD78Q40342761-C4602319-EEE4-4AD9-8FEB-0DA482FC54C4Q40569816-E3D846AA-C0FA-4CD8-89F7-0F22829321AAQ40707388-E62C5BC8-A2DC-46C8-99F2-9EFF367CE230Q40751048-70908EE6-1409-4C3E-8CDC-CD92B4626EAAQ41543095-4631BC1D-1FC8-4AE9-8D4F-586C39601BECQ41674522-4F6134DA-E39B-4AC0-AA42-83D6691C9F86Q41689708-94C4838C-19FD-4DE6-87E5-9226EE7A38FCQ41744181-210AEBA2-3BE7-4F39-8764-01814E106EC9Q41762221-21C85AD6-D921-4308-BCB5-AA9808811A89Q41764176-30F98B01-3F4A-4A8D-911B-D95A7A7F86E5Q41841345-332656EF-A6D9-427A-A870-52DD116FAA7FQ41919792-A9456A89-1130-407F-A0DA-F3E0A3198705Q41928977-68BA0C5A-9920-4065-A2AB-50FC8485F82DQ42451598-D002AC86-7E47-4FF1-A7DC-3389452915BA
P2860
Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Inhibitory effects of interleu ...... solated rat pancreatic islets.
@ast
Inhibitory effects of interleu ...... solated rat pancreatic islets.
@en
type
label
Inhibitory effects of interleu ...... solated rat pancreatic islets.
@ast
Inhibitory effects of interleu ...... solated rat pancreatic islets.
@en
prefLabel
Inhibitory effects of interleu ...... solated rat pancreatic islets.
@ast
Inhibitory effects of interleu ...... solated rat pancreatic islets.
@en
P356
P1433
P1476
Inhibitory effects of interleu ...... solated rat pancreatic islets.
@en
P2093
Andersson A
Hellerström C
P304
P356
10.1210/ENDO-121-4-1424
P407
P577
1987-10-01T00:00:00Z